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Abstract Langerhans’ cell histiocytosis (LCH) is a rare
and enigmatic clonal disorder that affects mainly children.
It is characterized by single or multiple granulomatous
mass lesions composed of cells with the Langerhans’ cell
phenotype. Clinical presentation and behavior are hetero-
geneous and can range from a solitary lytic bone lesion
(i.e., eosinophilic granuloma) with a favorable course to a
fatal disseminated leukaemia-like form, with a wide spec-
trum of intermediate clinical presentations between these
two extremes. Although LCH typically involves the bone,
lesions can be found in almost all organs. We are reporting
the case of a multisystem LCH in a 47-year-old patient
who presented with a panhypopituitarism and diabetes in-
sipidus, and who, 5 years later, developed mandibular,
mastoid and femoral lesions. The final diagnosis of LCH
was made on mandibular biopsy.
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Introduction
Langerhans’ cell histiocytosis (LCH) encompasses a dis-
parate group of diseases that has been referred to as Hand-
Schüller-Christian disease, Letterer-Siwe disease, eosino-
philic granuloma, histiocytosis X, Hashimoto Pritzker syn-
drome, self-healing histiocytosis, pure cutaneous histiocy-
tosis, Langerhans’ cell granulomatosis, type II histiocyto-
sis and non-lipid reticuloendotheliosis [8]. Langerhans’
cell histiocytosis is characterized by the proliferation of ab-
normal dendritic antigen-presenting histiocytes, known as
Langherhans’ cells, with an accompanying infiltrate of lym-
phocytes, eosinophils and neutrophils resulting in the de-
struction of a variety of tissues. Lesions may occur as lo-
calized lesions or as widespread systemic disease. Langher-
hans’ cells have distinctive morphologic and immunohis-
tochemical features (such as S-100 protein and CD1a anti-
gen) and represent an immature stage in the development
of interdigitating cells [7, 13]. Although some authors
have recently demonstrated clonal proliferation in all forms
of LCH, suggesting a neoplastic disorder, the exact etio-
pathogenesis of this enigmatic disease still remains obscure,
and the clinical course is unpredictable [17, 19]. Langer-
hans’ cell histiocytosis is usually considered to be a dis-
ease of childhood, with a peak incidence from 1 to 3 years.
However, it should be included in the differential diagno-
sis of adult patients, particularly those with multisystem
disease [18, 14, 4]. We are reporting a case of a 47-year-
old patient with a multisystemic form of Langherhans’
cell histiocytosis.
Case report
A 42-year-old patient was referred to the endocrinological depart-
ment in May 1997 for investigation of hypothyroidism. For 2 years,
he had complained of chronic fatigue, memory impairment, dimin-
ished libido, impotence, a loss of hair, gynecomastia and poly-
uria/polydipsia, which had started a few months previously. Pan-
hypopituitarism and central diabetes insipidus were diagnosed. Mag-
netic resonance imaging (MRI) showed evidence of an infiltrating
hypothalamic lesion involving the mammillary bodies, a slightly
thickened pituitary stalk (both homogeneously enhanced after in-
travenous gadolinium administration), a loss of the normal hyper-
intense signal of the posterior pituitary on T1-weighted images
(“bright spot”) and a partially empty sella (Fig. 1a). Microbiologi-
cal cultures of blood and CSF and serological markers for Tre-
ponema pallidum (VDRL, TPHA), Borrelia burgdorferi, Brucella
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melitensis, Bartonella henselae and HIV were negative. The re-
sults of cerebrospinal fluid immunoelectrophoresis were normal.
The level of angiotensin-converting enzyme, tested in blood and
CSF, was normal. Further work up with chest X-ray for sarcoïdosis
was normal. Neuropsychological tests showed a fronto-subcortical
syndrome characterized by severe short- and long-term memory
impairment (verbal and spatial) and marked executive dysfunction.
Replacement therapy was begun with oral levothyroxine 0.15 mg
daily, oral hydrocortisone acetate 20 mg daily, intramuscularly testos-
terone enantate 250 mg weekly and intranasal DDAVP 10 µg twice
daily. In July 1998, the patient presented with hyperosmolar dia-
betic decompensation, and treatment with insulin and metformine
850 mg twice daily was begun. A stereotaxic biopsy was per-
formed in January 1999 because the neuropsychological status of
the patient had become worse. Histopathologic examination revealed
gliosis together with non-specific perivascular chronic inflamma-
tory infiltration. Oral prednisone 60 mg daily for 3 months was be-
gun in March 1999, which stabilized the situation temporarily. The
follow-up MRI in June 1999 demonstrated a slight regression of
the hypothalamic lesion and the intensity of the contrast enhance-
ment following I.V. gadolinium administration (Fig. 1b). In July
2001, the patient complained of intermittent mandibular pain lo-
cated in the right molar and symphyseal areas. Periapical X-ray
showed a discrete periapical radiolucent lesion associated with a
non-vital mandibular right second molar (Fig. 2a) and a large peri-
apical radiolucent lesion associated with the non-vital mandibular
incisors (Fig. 2b). The right second mandibular molar was ex-
tracted and a devitalisation of the left central and lateral incisors
and right central incisor was performed. The panoramic radiograph
in December 2001 demonstrated a 3.5×3-cm well-defined non-cor-
ticated radiolucency with a scalloped superior border of the right
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Fig. 1 A Sagittal T1-weighted
MRI images showing an infil-
trating hypothalamic lesion in-
volving the mammillary bodies
and a slightly thickened pitu-
itary stalk both homogeneously
enhanced after intravenous
gadolinium administration.
B Sagittal T1-weighted MRI
images after 3 months of pred-
nisone therapy showing a slight
regression of the hypothalamic
lesion following gadolinium
administration. C Sagittal T1-
weighted MRI images after 
5 years showing an important
regression of the hypothalamic
lesion
Fig. 2 Periapical radiographs showing well-defined radiolucency
associated with the apex of the right mandibular second molar (A)
and mandibular incisors (B)
Fig. 3 Panoramic radiograph showing two unilocular radiolucen-
cies with well-defined margins in the right mandibular angle and
symphyseal region
mandibular area and the persistence of a punched-out radiolucency
in the symphyseal region (Fig. 3). Chronic osteomyelitis of the
mandible was diagnosed, and antibiotic and antiphlogistic therapy
was prescribed without any modification of the symptomatology.
In February 2002, the patient underwent a surgical curettage and
enucleation of both mandibular lesions, and the histologic diagno-
sis was that of chronic osteomyelitis. Follow-up panoramic radio-
graphs in April and August 2002 demonstrated no changes in the
size or radiographic characteristics of the mandibular lesions, but
the patient was asymptomatic. The patient presented in June 2002
with a 1-month history of transient otalgia, pain in the left retro-au-
ricular area, disturbances of gait, dizziness and left hypoacusia,
which had started 1 week previously. Otitis externa was diagnosed
and antibiotic and antiphlogistic therapy was given with a slight
modification of the symptomatology. One week later, he presented
at the hospital for the persistence of the symptomatology, appear-
ance of fever and significant red pulsatile swelling in the mastoid
region. Audiological evaluation revealed mixed hearing loss. The
CT-scan of the temporal bone revealed a massive destruction of
the bone of the mastoid area, and the patient underwent a left mas-
toidectomy (Fig. 4). The mastoid was destroyed by adherent gran-
ulations to the peri-temporal tissues, which prevented complete
surgical exeresis. Histopathological diagnosis was that of a chronic
non-specific inflammatory infiltrate.
In November 2002, the patient presented with a worsening of
mandibular pain associated with a discharge of whitish material in
the mouth. The intraoral exam revealed the persistence of a sinus
tract in the retromolar and symphyseal regions from which whitish
secretions were exuding. The panoramic radiograph demonstrated no
changes in the size or radiographic characteristics of the mandibu-
lar lesions. The patient underwent a new surgical curettage and
enucleation of both mandibular lesions. Microscopic examination
showed a diffuse infiltration of large pale-staining mononuclear
cells with indistinct cytoplasmic borders and indented vesicular
nuclei with a histiocytic appearance (Fig. 5a). The infiltrate was also
composed of a large amount of eosinophils, plasma cells and lym-
phocytes. Immunohistochemical studies using CD1a and S-100
protein antibodies showed that the histiocytic cells were consistent
with Langerhans’ cells (Fig. 5b). The final diagnosis was that of a
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Fig. 4 CT scan showing left mastoid infiltrated by soft tissue with
the destruction of the bony cortex (arrow)
Fig. 5 A Photomicrographs of the mandibular biopsy specimen
showing the cells of the infiltrate exhibiting the characteristic mor-
phologic features of Langerhans’ cells with a convoluted shape,
elongated nuclei exhibiting longitudinal grooves, and pale cyto-
plasm. Numerous eosinophils are also visible (haematoxylin-eosin,
original magnification ×25) B Immunostaining revealing numer-
ous strongly positive Langerhans’ cells for the CD1a antibody (im-
munoperoxidase, original magnification ×25)
Fig. 6 Technetium-99-m bone scan showing a lesion of the distal
epiphysis of the left femur, the persistence of a left temporal and
mandibular lesions and a frontal bone lesion
Langerhans’ cell histiocytosis. Previous temporal and mandibular
biopsies were reviewed and showed similar histological aspects.
Further work up for multifocal LCH with Technetium-99-m
bone scan (Fig. 6) and with chest and abdominal CT scans showed
evidence of a lesion of the distal epiphysis of the left femur, the
persistence of left temporal and mandibular lesions and a frontal
bone lesion. The brain MRI showed a significant regression of the
hypothalamic-pituitary axis lesion (Fig. 1c).
Given that the patient presented no symptoms at the 3-month
follow-up and given the lack of an international consensus con-
cerning treatment for adult LCH, the oncologists decided to pro-
pose no further treatment.
Discussion
In 1893, Hand reported a case of “polyuria and tuberculo-
sis” in a 3-year-old boy who presented with diabetes in-
sipidus (DI), skull lesions and exophthalmos [6]. In retro-
spect, he gave the first detailed clinical description of a
new group of polymorphic disorders involving the reticu-
loendothelial system (RES) and characterized by a histio-
cytic infiltrate. In 1953, Lichtenstein proposed the general
term “histiocytosis X” to describe a group of disorders in-
cluding Hand-Schuller-Christian syndrome, Letterer-Siwe
disease and eosinophilic granuloma [12]. Twenty years later,
Nezelof identified the Langerhans’ cells as the original
cells of histiocytisis X [15]. The Langerhans’ cell (LC), first
described by the Berlin medical student Paul Langerhans
in 1868, is a bone-marrow-derived dendritic, antigen-pre-
senting cell network, related to the mononuclear phago-
cyte system [10]. These cells are found in the skin, lymph
nodes, bone marrow, spleen and probably also the brain, and
have characteristic surface proteins, which identify them
as immature or mature. Within the LC is a five-layered
structure, the Birbeck granule, first seen by electron mi-
croscopy in 1961 [13]. The gene coding for the endocytic
receptor that induces the formation of Birbeck granules
has been identified and the protein called “langerin” [13,
17, 19]. Pathological LC is positive for HLA-DR, CD1a,
S100 and Fc receptor, as with their normal counterparts
[8, 13, 17, 19, 18]. In 1987, the Histiocyte Society estab-
lished a new classification of these disorders based on the
lineage of lesional cells and biological behavior related to
the ontogeny of histiocytes, and distinguished three classes:
class I or Langerhans’ cell histiocytosis (LCH); class II or
non-Langerhans’ cell histiocytosis; class III or malignant
histiocytosis [18].
Two main forms of LCH have been described: local-
ized LCH (eosinophilic granuloma) and multisystem LCH
(formerly Hand-Schuller-Christian syndrome or chronic
disseminated disease and Letterer-Siwe disease or acute
disseminated disease).
Langerhans’ cell histiocytosis often presents as a puz-
zling syndrome, which renders the diagnosis problematic.
Four important considerations explain the reasons for a
delayed diagnosis of LCH in our patient. First is the age
of the patient (42 years) at the time of the first symptoms.
In fact, these disorders are typically found in children –
more than 50% of all cases are seen in patients under age
10 – even though recent studies have shown that approxi-
mately 30% of LCH occur in adults, with an incidence
rate of 0.18/100,000 [18, 14, 4].
The second consideration concerns the presenting fea-
ture, namely the hypothalamic-pituitary lesion. In a series
of 47 adults with LCH, posterior pituitary involvement
was found to be the site of presentation in only 11 patients
[14]. By contrast, CNS involvement is not uncommon and
is strongly associated with the systemic disease, but it is
rarely found alone. The hypothalamic-pituitary axis re-
mains the unexplained site of predilection of CNS LCH;
however, hypothalamic mass lesions, as found in our pa-
tient, are not frequently encountered [5, 9]. Grois et al. re-
viewed 38 patients with CNS LCH and found only 4 pa-
tients (10%) with such lesions, whereas 22 patients (63%)
presented with structural changes in the pituitary region
(infundibular thickening in 8 patients and empty sella in
14 patients) [5]. Diabetes insipidus (DI) is the most com-
mon endocrine abnormality, reported in 5–50% of patients
with LCH, and it occurs when more than 80% of the par-
aventricular-supraoptic neurons are destroyed [9]. Dia-
betes insipidus occurs in only 5% of patients at the time of
original diagnosis, whereas it develops in one quarter to
one third of patients within 5 years of the diagnosis. Al-
though panhypopituitarism is reported in only 5–20% of
patients, it is almost always associated with DI [9].
The third consideration concerns the difficulty in ob-
taining a correct diagnosis of LCH from cerebral biopsy.
According to the literature, whether or not a biopsy should
be taken from such lesions still remains controversial.
Nevertheless, neurosurgeons are not inclined to approach
lesions in certain delicate regions, such as the hypothala-
mus, pons, basal ganglia and cerebellar peduncles, for only
the purpose of biopsy [5]. Normann et al. described four
stages of CNS LCH: hyperplastic-proliferative, granulo-
matous, xanthomatous and gliosis. The histological and
immunohistochemical LCH diagnostic features are more
likely to be found in the hyperplastic-proliferative stage,
whereas in the gliosis stage, as in our patient’s case, these
are more likely to be absent [5].
Finally, the fourth consideration concerns the clinical
presentation of the LCH, especially in a diabetic patient,
which can mimic an acute or chronic infection. Temporal
bone involvement may mimic otitis media and/or acute mas-
toiditis [11, 1, 16], and the mandibular involvement may
mimic a periapical infection and/or an osteomyelitis [3].
The skull is the most common site involved in both adults
and children, with calvarial bones as the most common
site for solitary lesions [8, 14, 4]. Ear disease has been re-
ported in 18–61% of cases, and when the temporal bone is
involved, 30% of patients present with bilateral disease
[11, 1]. A helpful feature that can distinguish LCH from
infectious otomastoiditis is the lack of middle ear or pos-
terior canal wall suppuration, because the LCH rarely in-
volves the middle ear cavity [16]. Our patient, on the con-
trary, presented with supporative otitis externa as well as
a significant involvement of the middle ear cavity, with
granulations adherent to the tympanic ossicles.
Jaw involvement (particularly the mandible) is usually
found in LCH patients. Howarth et al. [8] reviewed 314
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patients of the Mayo Clinic and found osseous lesions in
60%, 7% of whom had mandibular lesions. Of 47 patients
in the study by Baumgartner [4], the primary sites were
jaw (30%), skull (21%), extremities (17%), vertebrae (13%),
pelvis (13%), and ribs (6%). This is in contrast to children,
where the skull is the major bone area involved (40%),
and the jaw is involved in only 8% of those patients.
Radiographically, LCH lacks pathognomonic charac-
teristics and may mimic a wide spectrum of lesions such
as radicular cysts, periodontal disease, osteomyelitis and ma-
lignancies. Most often, lesions appear as sharply punched-
out radiolucencies, and when extensive alveolar involve-
ment occurs, the teeth appear as if they are “floating in
air.” Ardekian et al. reviewed 25 patients with 41 eosinophilic
granulomas and found pain to be the most common pre-
senting symptom (92% of patients), often accompanied
by swelling [3].
Treatment for LCH remains empirical even though sig-
nificant progress has been made in the understanding of
the pathophysiological basis of this disorder [8, 2]. Usu-
ally, the localized form of LCH as an isolated bone lesion
requires minimal treatment involving only biopsy or
curettage. If the patient is asymptomatic, then a “wait and
see” attitude is also possible, given the sometimes sponta-
neous resolution and healing of these lesions. Treatment
for multifocal/multisystem LCH normally benefits from
systemic therapy, which usually reduces morbidity and
mortality. As suggested by different international trials,
three important observations result: (1) the importance of
identifying the risk group that could benefit from treat-
ment with systemic cytotoxic agents; (2) that patients with
minimal involvement require minimal or no treatment; (3)
that in patients with extensive involvement, the initial re-
sponse to therapy predicts outcome [2].
Our patient benefited from enucleation and curettage
for temporal and mandibular lesions, as recommended by
the international literature [8, 14, 4, 2]. Although systemic
prednisone therapy considerably reduced the size of the
diencephalic lesion, substitutive hormonal treatment was
required. In fact, standard treatment for preventing or de-
laying hormonal deficit is yet to be determined; therefore,
the damage to the pituitary/hypothalamus axis results in
life-long hormonal replacement.
In conclusion, it should be kept in mind that multisys-
tem LCH can occur in adults and that particular attention
must be paid to osteolytic jaw lesions associated with en-
docrine or neurological symptoms.
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